Catalent’s Belgium manufacturing operations were slapped with a second Form 483 by the FDA ... In the wake of an FDA inspection conducted between August 10 and August 18 at the Brussels ...

Catalent Inc is close to reaching a settlement with activist investor Elliott Investment Management which will ... The Brussels plant began filling Wegovy injection pens in 2021 but problems there ...

Problems at Catalent’s Brussels plant were previously pegged as part of the reason behind a supply squeeze on Novo Nordisk’s Wegovy in 2022.

In April, Catalent reported productivity challenges and higher-than-expected costs at its drug product and drug substance manufacturing facilities in Bloomington, Indiana, and Brussels, Belgium.

Catalent, one of the top ... had coincided with higher-than-expected costs and production challenges at its facilities in Indiana and in Brussels. ...

BRUSSELS, Dec 6 (Reuters) - Novo Holdings on Friday gained unconditional EU antitrust approval for its $16.5 bln acquisition of U.S. contract drug maker Catalent (CTLT.N), opens new tab after EU ...

Ozempic Maker Strikes $11B Deal With Catalent As It Rushes To Meet Massive Weight-Loss Drug Demand. ... Brussels, Belgium, and Bloomington, Indiana, specialize in the sterile filling of drugs.

Novo Holdings to purchase drug manufacturer Catalent for $16.5 billion, a deal that could expand Wegovy ... Novo will pick up sites that focus on filling drugs in Italy, Brussels, and ...

Novo Nordisk plans to buy from the holding company three sites — Brussels; Anagni, Italy; ... Catalent shares in January spiked on news of the planned acquisition to near $60.

The first facility is Catalent's factory in Brussels. Reuters reported this week that the second facility is Thermo Fisher's TMO.N factory in Greenville, North Carolina.

Catalent common stock holders are set to obtain $63.50 per share in cash. advertisement. GlobalData. ... Brussels, Belgium and Anagni, Italy along with related assets from Novo Holdings.

Pharmalittle: We’re reading about Novo buying Catalent, Amgen’s obesity drug, and more. By Ed Silverman Feb. 5, 2024. ... Brussels, and Bloomington, Ind., all of which have been doing work for ...